Clinical Expert Commentaries

Clinical Expert Commentaries published on March 7, 2014 in General Education
Dr. Robert Kyle discusses the discovery and history of therapeutic agents for multiple myeloma.
Dr. Shaji Kumar defines clinical trial endpoints and how each endpoint is evaluated.
Clinical Expert Commentaries published on July 2, 2013 in Response Assessment
Sandra Kurtin discusses the management and risk reduction strategies associated with carfilzomib.
Clinical Expert Commentaries published on June 28, 2013 in Response Assessment
Sandra Kurtin discusses the management and risk reduction strategies associated with pomalidomide.
Clinical Expert Commentaries published on May 17, 2013 in Response Assessment
Sandra Kurtin discusses the administration of subcutaneous bortezomib.
Clinical Expert Commentaries published on May 9, 2013 in Clinical Trials
Dr. Robert Orlowski discusses the importance of clinician access to clinical trial information for improved patient treatment.
Clinical Expert Commentaries published on January 23, 2013 in Stem Cell Transplant
Dr. Sergio Giralt discusses the treatment goals in stem cell transplant in eligible patients.
Clinical Expert Commentaries published on May 3, 2011 in Comorbidities/SEs
Dr. Lonial discusses managing and treating asthenia and cognitive impairment side effects induced by therapeutic agents.
Clinical Expert Commentaries published on March 10, 2011 in Renal Impairment
Dr. Mohrbacher discusses identifying, assessing and managing dysfunction in the multiple myeloma patient.
Page 1 of 3
Results 1 - 10 of 26